These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 12513801)

  • 81. The role of B7 costimulation in T-cell immunity.
    Harris NL; Ronchese F
    Immunol Cell Biol; 1999 Aug; 77(4):304-11. PubMed ID: 10457196
    [TBL] [Abstract][Full Text] [Related]  

  • 82. GAD65-reactive T cells are activated in patients with autoimmune type 1a diabetes.
    Viglietta V; Kent SC; Orban T; Hafler DA
    J Clin Invest; 2002 Apr; 109(7):895-903. PubMed ID: 11927616
    [TBL] [Abstract][Full Text] [Related]  

  • 83. CD28: a signalling perspective.
    Ward SG
    Biochem J; 1996 Sep; 318 ( Pt 2)(Pt 2):361-77. PubMed ID: 8809021
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Differential requirements of naïve and memory T cells for CD28 costimulation in autoimmune pathogenesis.
    Perrin PJ; Lovett-Racke A; Phillips SM; Racke MK
    Histol Histopathol; 1999 Oct; 14(4):1269-76. PubMed ID: 10506942
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Treatment of murine lupus with CTLA4Ig.
    Finck BK; Linsley PS; Wofsy D
    Science; 1994 Aug; 265(5176):1225-7. PubMed ID: 7520604
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Blockade of the CD28 co-stimulatory pathway: a means to induce tolerance.
    Boussiotis VA; Gribben JG; Freeman GJ; Nadler LM
    Curr Opin Immunol; 1994 Oct; 6(5):797-807. PubMed ID: 7530013
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Antigen presentation by parenchymal cells: a route to peripheral tolerance?
    Marelli-Berg FM; Lechler RI
    Immunol Rev; 1999 Dec; 172():297-314. PubMed ID: 10631955
    [TBL] [Abstract][Full Text] [Related]  

  • 88. [The molecular mechanism of costimulatory signal for T cell activation].
    Uede T
    Nihon Rinsho; 1995 Oct; 53(10):2597-603. PubMed ID: 8531379
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Immunosuppression in vivo by a soluble form of the CTLA-4 T cell activation molecule.
    Linsley PS; Wallace PM; Johnson J; Gibson MG; Greene JL; Ledbetter JA; Singh C; Tepper MA
    Science; 1992 Aug; 257(5071):792-5. PubMed ID: 1496399
    [TBL] [Abstract][Full Text] [Related]  

  • 90. The expression of T cell related costimulatory molecules in multiple myeloma.
    Brown RD; Pope B; Yuen E; Gibson J; Joshua DE
    Leuk Lymphoma; 1998 Oct; 31(3-4):379-84. PubMed ID: 9869202
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Evidence for an additional ligand, distinct from B7, for the CTLA-4 receptor.
    Razi-Wolf Z; Galvin F; Gray G; Reiser H
    Proc Natl Acad Sci U S A; 1993 Dec; 90(23):11182-6. PubMed ID: 7504299
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Intracellular capture of B7 in antigen-presenting cells reduces costimulatory activity.
    Sheriff A; Vogt B; Baumgart M; Montag C; Hollenbach B; Schenk JA; Ulrich J; Elías F; Micheel B
    Biochem Biophys Res Commun; 2003 Feb; 301(4):873-8. PubMed ID: 12589793
    [TBL] [Abstract][Full Text] [Related]  

  • 93. The function of costimulatory molecules and the development of IL-4-producing T cells.
    Gause WC; Halvorson MJ; Lu P; Greenwald R; Linsley P; Urban JF; Finkelman FD
    Immunol Today; 1997 Mar; 18(3):115-20. PubMed ID: 9078683
    [TBL] [Abstract][Full Text] [Related]  

  • 94. The immune response induced in vivo by dendritic cells is dependent on B7-1 or B7-2, but the inhibition of both signals does not lead to tolerance.
    Lespagnard L; Mettens P; De Smedt T; Bazin H; Urbain J; Leo O; Moser M
    Int Immunol; 1998 Mar; 10(3):295-304. PubMed ID: 9576617
    [TBL] [Abstract][Full Text] [Related]  

  • 95. The role of CTLA-4 in the regulation of T cell immune responses.
    McCoy KD; Le Gros G
    Immunol Cell Biol; 1999 Feb; 77(1):1-10. PubMed ID: 10101680
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Specific blockade of CTLA-4/B7 interactions results in exacerbated clinical and histologic disease in an actively-induced model of experimental allergic encephalomyelitis.
    Hurwitz AA; Sullivan TJ; Krummel MF; Sobel RA; Allison JP
    J Neuroimmunol; 1997 Mar; 73(1-2):57-62. PubMed ID: 9058759
    [TBL] [Abstract][Full Text] [Related]  

  • 97. CD28-B7 bidirectional signaling: a two-way street to activation.
    Logue EC; Sha WC
    Nat Immunol; 2004 Nov; 5(11):1103-5. PubMed ID: 15496947
    [No Abstract]   [Full Text] [Related]  

  • 98. Role of the CTLA-4 receptor in T cell activation and immunity. Physiologic function of the CTLA-4 receptor.
    Scheipers P; Reiser H
    Immunol Res; 1998; 18(2):103-15. PubMed ID: 9844829
    [TBL] [Abstract][Full Text] [Related]  

  • 99. CD80 cytoplasmic domain controls localization of CD28, CTLA-4, and protein kinase Ctheta in the immunological synapse.
    Tseng SY; Liu M; Dustin ML
    J Immunol; 2005 Dec; 175(12):7829-36. PubMed ID: 16339518
    [TBL] [Abstract][Full Text] [Related]  

  • 100. [Progress in the study on the molecules in CD28 family].
    Feng YL; Zhu LP; He W
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Oct; 24(5):536-9. PubMed ID: 12905782
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.